Literature DB >> 23963821

Bone mineral density following surgical oophorectomy and tamoxifen adjuvant therapy for breast cancer.

Richard R Love1, Gregory S Young, Adriano V Laudico, Nguyen Van Dinh, Gemma B Uy, Le Hong Quang, Arturo S De La Peña, Rodney B Dofitas, Orlino C Bisquera, Stephen S S Siguan, Jonathan D S Salvador, Maria Rica Mirasol-Lumague, Narciso S Navarro, Nguyen Dieu Linh, David Jarjoura.   

Abstract

BACKGROUND: In premenopausal women treated for breast cancer, loss of bone mineral density (BMD) follows from menopause induced by chemotherapy or loss of ovarian function biochemically or by surgical oophorectomy. The impact on BMD of surgical oophorectomy plus tamoxifen therapy has not been described.
METHODS: In 270 Filipino and Vietnamese premenopausal patients participating in a clinical trial assessing the impact of the timing in the menstrual cycle of adjuvant surgical oophorectomy on breast cancer outcomes, BMD was measured at the lumbar spine and femoral neck before this treatment, and at 6, 12, and 24 months after surgical and tamoxifen therapies.
RESULTS: In women with a pretreatment BMD assessment and at least 1 other subsequent BMD assessment, no significant change in femoral neck BMD was observed over the 2-year period (-0.006 g/cm2 , -0.8%, P = .19), whereas in the lumbar spine, BMD fell by 0.045 g/cm2 (4.7%) in the first 12 months (P < .0001) and then began to stabilize.
CONCLUSIONS: Surgically induced menopause with tamoxifen treatment is associated with loss of BMD at a rate that lessens over 2 years in the lumbar spine and no significant change of BMD in the femoral neck.
© 2013 American Cancer Society.

Entities:  

Keywords:  adjuvant drug therapy; bone mineral density; breast cancer; femoral neck; menopause; oophorectomy; spine; tamoxifen

Mesh:

Substances:

Year:  2013        PMID: 23963821     DOI: 10.1002/cncr.28302

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  5 in total

1.  Effects of zoledronic acid versus placebo on bone mineral density and bone texture analysis assessed by the trabecular bone score in premenopausal women with breast cancer treatment-induced bone loss: results of the ProBONE II substudy.

Authors:  M Kalder; I Kyvernitakis; U S Albert; M Baier-Ebert; P Hadji
Journal:  Osteoporos Int       Date:  2014-11-08       Impact factor: 4.507

2.  Timing of adjuvant surgical oophorectomy in the menstrual cycle and disease-free and overall survival in premenopausal women with operable breast cancer.

Authors:  Richard R Love; Adriano V Laudico; Nguyen Van Dinh; D Craig Allred; Gemma B Uy; Le Hong Quang; Jonathan Disraeli S Salvador; Stephen Sixto S Siguan; Maria Rica Mirasol-Lumague; Nguyen Dinh Tung; Noureddine Benjaafar; Narciso S Navarro; Tran Tu Quy; Arturo S De La Peña; Rodney B Dofitas; Orlino C Bisquera; Nguyen Dieu Linh; Ta Van To; Gregory S Young; Erinn M Hade; David Jarjoura
Journal:  J Natl Cancer Inst       Date:  2015-03-19       Impact factor: 13.506

3.  Inactivated Sendai virus strain Tianjin induces apoptosis in breast cancer MCF-7 cells by promoting caspase activation and Fas/FasL expression.

Authors:  Li-Ying Shi; Zhe Han; Xiao-Xia Li; Mei Li; Han Han; Jun Chen; Sitao Zang
Journal:  Cancer Biother Radiopharm       Date:  2014-12-17       Impact factor: 3.099

4.  Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.

Authors:  Pengfei Li; Youming Guo; Grant Bledsoe; Zhirong Yang; Lee Chao; Julie Chao
Journal:  Exp Cell Res       Date:  2016-01-11       Impact factor: 3.905

5.  Analysis of the Influence of Hormone Replacement Therapy on Osteocalcin Gene Expression in Postmenopausal Women.

Authors:  Mansur Rahnama; Izabela Jastrzębska-Jamrogiewicz; Rafał Jamrogiewicz; Grzegorz Trybek
Journal:  Biomed Res Int       Date:  2015-08-19       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.